Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
AIkido Pharma Inc. stock logo
AIKI
AIkido Pharma
$5.80
+6.8%
$5.06
$3.31
$11.48
$31.81M0.9379,326 shs282,385 shs
Data Knights Acquisition Corp. stock logo
DKDCA
Data Knights Acquisition
$0.68
+100.6%
$0.41
$5.00
$13.51
$3.53M0.1839,705 shs494.06 million shs
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
$0.75
$0.53
$0.22
$3.85
$25.47M1.88217,168 shs172,158 shs
PPD, Inc. stock logo
PPD
PPD
$47.28
$47.27
$31.54
$47.41
$16.61B1.961.91 million shsN/A
20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
AIkido Pharma Inc. stock logo
AIKI
AIkido Pharma
+6.81%+15.08%+26.09%+15.54%+206.88%
Data Knights Acquisition Corp. stock logo
DKDCA
Data Knights Acquisition
+90.08%+76.32%+66.80%+26.33%-30.39%
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
0.00%+13.64%+50.00%+5.62%-79.05%
PPD, Inc. stock logo
PPD
PPD
0.00%0.00%0.00%0.00%0.00%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
AIkido Pharma Inc. stock logo
AIKI
AIkido Pharma
N/AN/AN/AN/AN/AN/AN/AN/A
Data Knights Acquisition Corp. stock logo
DKDCA
Data Knights Acquisition
N/AN/AN/AN/AN/AN/AN/AN/A
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
0.6448 of 5 stars
0.03.00.00.02.31.70.0
PPD, Inc. stock logo
PPD
PPD
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
AIkido Pharma Inc. stock logo
AIKI
AIkido Pharma
0.00
N/AN/AN/A
Data Knights Acquisition Corp. stock logo
DKDCA
Data Knights Acquisition
0.00
N/AN/AN/A
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
0.00
N/AN/AN/A
PPD, Inc. stock logo
PPD
PPD
0.00
N/AN/AN/A
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
AIkido Pharma Inc. stock logo
AIKI
AIkido Pharma
$10K3,181.30N/AN/A$19.27 per share0.30
Data Knights Acquisition Corp. stock logo
DKDCA
Data Knights Acquisition
N/AN/A$0.01 per share111.42($1.82) per shareN/A
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
$116.61M0.22$0.25 per share3.03N/A
PPD, Inc. stock logo
PPD
PPD
$4.68B3.55$1.99 per share23.71($1.21) per share-39.07
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
AIkido Pharma Inc. stock logo
AIKI
AIkido Pharma
-$7.17M-$3.88N/AN/AN/AN/A-18.21%-16.94%N/A
Data Knights Acquisition Corp. stock logo
DKDCA
Data Knights Acquisition
$340K-$0.19N/AN/AN/AN/A-5.55%N/A
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
$9.28MN/A0.00N/AN/AN/AN/AN/A
PPD, Inc. stock logo
PPD
PPD
$153.69M$1.0047.2825.982.116.11%-89.48%7.94%N/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
AIkido Pharma Inc. stock logo
AIKI
AIkido Pharma
N/AN/AN/AN/AN/A
Data Knights Acquisition Corp. stock logo
DKDCA
Data Knights Acquisition
N/AN/AN/AN/AN/A
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
N/AN/AN/AN/AN/A
PPD, Inc. stock logo
PPD
PPD
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
AIkido Pharma Inc. stock logo
AIKI
AIkido Pharma
N/A
29.54
29.54
Data Knights Acquisition Corp. stock logo
DKDCA
Data Knights Acquisition
N/AN/AN/A
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
N/AN/AN/A
PPD, Inc. stock logo
PPD
PPD
N/A
1.23
1.23

Institutional Ownership

CompanyInstitutional Ownership
AIkido Pharma Inc. stock logo
AIKI
AIkido Pharma
10.88%
Data Knights Acquisition Corp. stock logo
DKDCA
Data Knights Acquisition
35.35%
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
87.46%
PPD, Inc. stock logo
PPD
PPD
87.82%

Insider Ownership

CompanyInsider Ownership
AIkido Pharma Inc. stock logo
AIKI
AIkido Pharma
8.60%
Data Knights Acquisition Corp. stock logo
DKDCA
Data Knights Acquisition
45.72%
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
7.60%
PPD, Inc. stock logo
PPD
PPD
1.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
AIkido Pharma Inc. stock logo
AIKI
AIkido Pharma
45.49 million5.01 millionNot Optionable
Data Knights Acquisition Corp. stock logo
DKDCA
Data Knights Acquisition
25.17 million2.81 millionNot Optionable
Luna Innovations Incorporated stock logo
LUNA
Luna Innovations
39033.96 million31.38 millionOptionable
PPD, Inc. stock logo
PPD
PPD
26,000351.40 million344.72 millionNot Optionable

Recent News About These Companies

MISSING: Pooler police looking for juvenile girl
Milwaukee Brewers at Chicago Cubs, ppd.
Pittsburgh Pirates at Detroit Tigers, ppd.

New MarketBeat Followers Over Time

Media Sentiment Over Time

AIkido Pharma stock logo

AIkido Pharma NASDAQ:AIKI

$5.80 +0.37 (+6.81%)
As of 06/24/2025

AIkido Pharma Inc., a biotechnology company, focuses on developing small-molecule anti-cancer therapeutics. The company's pipeline of therapeutics includes therapies for prostate cancer, pancreatic cancer, acute myeloid leukemia (AML), and acute lymphoblastic leukemia. It is developing DHA-dFdC, a pancreatic drug candidate; and KPC34, a small molecule treatment for acute myeloid leukemia and acute lymphoblastic leukemia. The company is also developing an antiviral platform that inhibits replication of viruses, including influenza virus, Ebolavirus and Marburg virus, SARS-CoV, MERS-CoV, and SARS-CoV-2. It has license agreements with the University of Texas, University of Maryland Baltimore, Silo Pharma Inc., and Wake Forest University Health Sciences. The company was formerly known as Spherix Incorporated and changed its name to AIkido Pharma Inc. in March 2021. AIkido Pharma Inc. was founded in 1967 and is headquartered in New York, New York.

Data Knights Acquisition stock logo

Data Knights Acquisition NASDAQ:DKDCA

$0.68 +0.34 (+100.65%)
As of 06/24/2025

Data Knights Acquisition Corp. does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in the data centers and internet technology sectors. Data Knights Acquisition Corp. was incorporated in 2021 and is based in Frome, the United Kingdom.

Luna Innovations stock logo

Luna Innovations NASDAQ:LUNA

$0.75 0.00 (0.00%)
As of 06/25/2025 03:45 PM Eastern

Luna Innovations Incorporated provides fiber optic test, measurement, and control products worldwide. The company offers test and measurement equipment for fiber optic components and sub-assemblies; polarization control products, including components, modules, and instruments to measure, manage, and control polarization and group delay in fiber optic networks; tunable lasers; and single frequency lasers. It also provides ODiSI sensing solution, which provides distributed strain and temperature measurements; distributed temperature sensing system; hyperion sensing products; Terahertz Sensing Systems that provide precise single and multi-layer thickness, density, basis weight, and caliper thickness measurements; and distributed acoustic sensing products. The company primarily markets its fiber optic test, measurement, and control products to telecommunications companies, defense agencies, government system integrators, researchers, original equipment manufacturers, distributors, testing labs, and strategic partners directly, as well as through manufacturer representative organizations, partner and distribution channels, technical sales engineers, value added resellers, and independent sales representatives. Luna Innovations Incorporated was incorporated in 1990 and is headquartered in Roanoke, Virginia.

PPD stock logo

PPD NASDAQ:PPD

PPD, Inc., together with its subsidiaries, provides drug development services to the biopharmaceutical industry worldwide. The company operates through two segments, Clinical Development Services and Laboratory Services. It offers clinical development services, including product development and consulting, early development, Phases II-IV clinical trial management, accelerated enrollment, peri-and post-approval, and medical communications services. The company also provides laboratory services comprising bioanalytical, biomarker, vaccine science, good manufacturing practice, and central laboratory services. It serves pharmaceutical, biotechnology, medical device, and government organizations, as well as other industry participants. The company has a collaboration with Science 37 to design, build, test, implement, and execute digital trials using Science 37's DCT SaaS-based technology platform. PPD, Inc. was founded in 1985 and is headquartered in Wilmington, North Carolina.